Skip to main content

About your Search

20110701
20110731
Search Results 0 to 1 of about 2
the recommended treatment. here's dr. jon lapook. >> think it's ready? >> yup. >> reporter: six years ago, adam schaffer was enjoying thanksgiving with his family until... >> i went to the bathroom and there was a whole bunch of red and it was very scary. >> reporter: he was just 44 years old. the doctors diagnosis floored him. >> he says "you have bladder cancer." and you could feel the room spinning. >> reporter: his first doctor removed the tumor but did not follow up with standard recommended treatment. failure to follow guidelines is dangerously common and one reason bladder cancer survival has not improved in 25 years says u.c.l.a.'s dr. karim chamie. >> if we were to get a report card based on our performance with these guideline measures i would say we bead failing. >> reporter: for the first two years after finding early bladder cancer, doctors are supposed to test the urine for abnormal cells and examine the inside of the bladder every three months. they're also supposed to fill it with an anticancer drug at least six times. but among 4,500 patients only one receive tad recommended ca
. dr. jon lapook has more. >> reporter: worrisome news for the more than 7 million americans who have taken chantix. a new analysis links the pill to a 72% increase in the risk of heart problems. johns hopkins dr. singh led the research. >> it is causing the same problems that we are trying to prevent, that's why it's not worth the risk. we need to prevent cardio disease among smokers, not increase. >> reporter: the review combines 14 studies involving more than 8,000 patients. while a 72% increased risk sounds alarming, the companion editorial titles, is it a heartbreaker? notes that cardiovascular problems including chest pain, heart attack and stroke are still rare. occurring in only about 1% of patients taking chantix. the drugmaker pfizer questions the way the analysis was conducted. dr. gail caldwell is vice president of medical affairs for pfizer. >> we will continue to do a more in-depth look as the fda is asking us to do but to date we have not seen evidence of important risks to the heart health of patients. from chantix. >> reporter: in mid june the fda warned chantix might
Search Results 0 to 1 of about 2